Table 4.
rs2230054 | |||||||||
---|---|---|---|---|---|---|---|---|---|
Genotype | Genetic model | ||||||||
Dominant | Recessive | Overdominant | |||||||
CC VS TC/TT | CC/TC VS TT | CC/TT VS TC | |||||||
CC | TC | TT | OR (95% CI) | p Value | OR (95% CI) | pValue | OR (95% CI) | p Value | |
PE | |||||||||
SPE | 84 (42.6%) | 104 (52. 8%) | 9 (4.6%) | 1.33 (0.91–1.95) | 0.13 | 0.92 (0.38–2.23) | 0.86 | 1.35 (0.93–1.97) | 0.12 |
MPE | 17 (41.5%) | 23 (56.1%) | 1 (2.4%) | 1.40 (0.72–2.74) | 0.32 | 0.48 (0.06–3.80) | 0.44 | 1.54 (0.79–3.01) | 0.2 |
SPE | |||||||||
Early‐onset | 35 (42.2%) | 45 (54.2%) | 3 (3.6%) | 1.36 (0.82–2.25) | 0.23 | 0.72 (0.20–2.62) | 0.61 | 1.43 (0.87–2.36) | 0.16 |
Late‐onset | 49 (43.0%) | 59 (51.8%) | 6 (5.2%) | 1.32 (0.84–2.06) | 0.23 | 1.07 (0.39–2.93) | 0.9 | 1.30 (0.83–2.03) | 0.25 |
Control | 121 (49.8%) | 110 (45.3%) | 12 (4.9%) |
PE: preeclampsia; MPE: mild preeclampsia; SPE: severe preeclampsia.